Answers are grounded in this paper and cite their sources.
Clinical evaluation examines EAPSDAS performance in intensive care patients with antiphospholipid syndrome, highlighting the need to link activity scores with catastrophic disease criteria.
The European Alliance of Associations for Rheumatology (EULAR) antiphospholipid syndrome (APS) disease activity score (EAPSDAS) was recently coined as a novel tool to measure disease activity in patients with APS [1]. Importantly, some patients with an active APS may require intensive care unit (ICU) admission because of organ dysfunctions caused by macrovascular and/or microvascular thromboses with or without meeting the catastrophic APS (CAPS) classification criteria [2]. To date, whether fulfilment of these criteria is associated with a higher EAPSDAS score is unknown.
No takes yet. Share an insight, caveat, or question.
Azoulay et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: